Alison Bond, Ph.D. has been appointed to lead Quanticate’s new Pharmacovigilance Services team. The new service offers clinical trial and post-marketing pharmacovigilance for comprehensive surveillance throughout the product lifecycle. These services include adverse event case management and reporting, signal detection and evaluation, literature screening and review, and document preparation and submission. Prior to joining the company, Dr. Bond served as an independent pharmacovigilance cons...